To do so, we integrated expression, mutation and dependency data from the Cancer Cell Line Encyclopedia (CCLE) and the Cancer Dependency Map (DepMap) to investigate whether mutational status of EP300 or CBP predicted differential response to CCS1477 or A485. This evidence concerns the gene EP300 and cancer.